Uncategorized

A third party may have accessed test results and Social Security numbers held by the genetic testing company.

The discontinuation of the uveitis study adds to Regeneron’s series of clinical setbacks, including the Phase 3 failures of the Dupixent follow-up itepekimab and an investigational combo regimen for melanoma.

Seema Verma, a former administrator for the CMS, makes the case for better connecting healthcare data as the agency marks the first anniversary of its “Kill the Clipboard” initiative.

Sam Asgarian, Guardant Health’s vice president of clinical development, discusses the progress and challenges of blood-based testing in colorectal and multicancer screening.

This is the third recent acquisition conducted by Denmark’s LEO Pharma in medical dermatology, a portfolio that marked 12% growth in the first half of the year.

The initial batch of biosimilars includes copies of Amgen, Eli Lilly and GSK drugs that collectively generate billions of dollars in annual revenues.

With demand for pharma services historically lagging changes in biotech funding, analysts expect CDMOs to experience an uptick in activity in late 2026 or early 2027.

The discontinuation of the uveitis study adds to Regeneron’s series of clinical setbacks, including the Phase 3 failures of the Dupixent follow-up itepekimab and an investigational combo regimen for melanoma.

With a Phase 3 trial reducing serious and severe hypoglycemic episodes following weight loss surgery, Amylyx Pharmaceuticals plans to file for approval this year. If granted market entry, avexitide could hit peak sales of $1.7 billion worldwide, analysts estimate.

Cuando el sistema financiero de un país colapsa por una hiperinflación descontrolada o un bloqueo bancario total, ocurre un fenómeno tan fascinante como devastador: el dinero fiduciario deja de cumplir sus funciones básicas. El billete de papel pierde valor más r&a …